ES2108694T3 - Inhibidor de proteasa. - Google Patents

Inhibidor de proteasa.

Info

Publication number
ES2108694T3
ES2108694T3 ES90907508T ES90907508T ES2108694T3 ES 2108694 T3 ES2108694 T3 ES 2108694T3 ES 90907508 T ES90907508 T ES 90907508T ES 90907508 T ES90907508 T ES 90907508T ES 2108694 T3 ES2108694 T3 ES 2108694T3
Authority
ES
Spain
Prior art keywords
pct
inhibitor
gelin
chymotrypsin
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90907508T
Other languages
English (en)
Inventor
Anthony Atkinson
Asgar Electricwala
Roy Thomas Sawyer
Sicard Nils Von
Gerard Voerman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Application granted granted Critical
Publication of ES2108694T3 publication Critical patent/ES2108694T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

ESTA INVENCION SE REFIERE A UN NUEVO INHIBIDOR DE LA PROTEASA QUE LE HEMOS LLAMADO GELIN, Y A LAS PREPARACIONES COSMETICAS Y FARMACEUTICAS QUE CONTIENEN ESTE COMPUESTO. EL GELIN ES UN INHIBIDOR DE LA ELASTASA LEUCO Y CIMOTRIPSINA HUMANA Y PORCINA. EL GELIN TIENE PROPIEDADES ANTIBIOTICAS ESPECIFICAS. TAMBIEN SE REFIERE A LA NUEVA UTILIZACION DEL EGLIN, OTRO INHIBIDOR DE LA CIMOTRIPSINA EN APLICACIONES COSMETICAS.
ES90907508T 1989-04-14 1990-04-12 Inhibidor de proteasa. Expired - Lifetime ES2108694T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8900943A NL8900943A (nl) 1989-04-14 1989-04-14 Protease inhibitor.

Publications (1)

Publication Number Publication Date
ES2108694T3 true ES2108694T3 (es) 1998-01-01

Family

ID=19854482

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90907508T Expired - Lifetime ES2108694T3 (es) 1989-04-14 1990-04-12 Inhibidor de proteasa.

Country Status (12)

Country Link
US (1) US5397694A (es)
EP (1) EP0466833B1 (es)
JP (1) JP3101629B2 (es)
KR (1) KR0167344B1 (es)
AT (1) ATE157989T1 (es)
AU (1) AU648252B2 (es)
CA (1) CA2053242C (es)
DE (1) DE69031424T2 (es)
DK (1) DK0466833T3 (es)
ES (1) ES2108694T3 (es)
NL (1) NL8900943A (es)
WO (1) WO1990012808A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0662514A1 (en) * 1994-01-07 1995-07-12 Ciba-Geigy Ag Hirustasin, an antistasin type serine proteinase inhibitor from Hiruda
NZ270194A (en) * 1994-01-07 1996-05-28 Ciba Geigy Ag Hirustasin, a serine protease inhibitor from hirudo medicinalis
KR0137519B1 (ko) * 1995-04-27 1998-04-30 심상철 한국산 흡혈종 거머리(Hirudo nipponia)로 부터 분리한 일래스테이즈 억제 단백질 및 그의 제조방법
GB2304048A (en) * 1995-08-12 1997-03-12 John William Carson Medicament containing saliva extract
KR100224383B1 (ko) 1996-09-09 1999-10-15 윤덕용 거머린에서 유도된 단백질분해효소 억제활성을지닌 펩타이드
FR2755015B1 (fr) * 1996-10-25 1998-12-24 Sod Conseils Rech Applic Utilisation d'un extrait flavonoidique de ginkgo biloba substantiellement depourvu de terpenes, dans le domaine buccodentaire, et composition contenant un tel extrait
FR2763944B1 (fr) * 1997-06-03 2000-12-15 Centre Nat Rech Scient Nouveaux derives de coumarines, leurs procedes de preparation et leur application comme medicaments en tant qu'inhibiteurs de proteases
AT406120B (de) * 1997-08-28 2000-02-25 Immuno Ag Gewebekleber
US7063838B1 (en) * 1999-09-24 2006-06-20 Proteon Therapeutics Llc Methods for treating an artery or vein in a human subject
DK1923068T3 (da) * 1999-09-24 2011-06-27 Proteon Therapeutics Inc Systemer og fremgangsmåder til åbning af blokerede biologiske kanaler
US7632494B2 (en) * 1999-09-24 2009-12-15 Proteon Therapeutics, Inc. Methods for enlarging the diameter of a biological conduit in a human subject
US20080025966A1 (en) * 2004-01-30 2008-01-31 Currie Mark G Methods And Compositions For The Treatment Of Gastrointestinal disorders
US20110034396A1 (en) * 2005-09-28 2011-02-10 Biovascular, Inc. Methods and compositions for inhibiting cell migration and treatment of inflammatory conditions
US7691839B2 (en) * 2005-09-28 2010-04-06 Biovascular, Inc. Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation
EP2316465A1 (en) * 2009-10-15 2011-05-04 Centre National De La Recherche Scientifique Use of extract of leeches' saliva as anti-bacterial agent for the manufacture of different compositons

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2808396C2 (de) * 1978-02-27 1984-04-19 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Protease-Inhibitoren
DE3445532A1 (de) * 1984-12-13 1986-06-19 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Hirudin-pa, desulfatohirudine-pa, verfahren zur herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten

Also Published As

Publication number Publication date
KR920701247A (ko) 1992-08-11
DE69031424T2 (de) 1998-04-09
DK0466833T3 (da) 1998-04-14
AU648252B2 (en) 1994-04-21
ATE157989T1 (de) 1997-09-15
AU5549290A (en) 1990-11-16
JPH04507238A (ja) 1992-12-17
NL8900943A (nl) 1990-11-01
CA2053242C (en) 2000-09-19
DE69031424D1 (de) 1997-10-16
WO1990012808A1 (en) 1990-11-01
US5397694A (en) 1995-03-14
KR0167344B1 (ko) 1999-01-15
CA2053242A1 (en) 1990-10-15
EP0466833A1 (en) 1992-01-22
JP3101629B2 (ja) 2000-10-23
EP0466833B1 (en) 1997-09-10

Similar Documents

Publication Publication Date Title
ES2108694T3 (es) Inhibidor de proteasa.
MY119778A (en) Androstenone derivative.
ES2031804T1 (es) Derivado del activador de plasminogeno de tejido.
HK1049103A1 (zh) 含有利托那韋(abt-538)並與茚地那韋(mk-639)結合藥物的組合物以及他們在治療艾滋病中的用途
DK0799209T3 (da) Sulfonamider
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
DE69000641D1 (de) Imipramin enthaltende arzneizubereitungen.
DE69420145D1 (de) Behandlung präkanzeröser läsionen durch muramylpeptide
ATE213633T1 (de) Lamotrigin haltiges arzneimittel
DK0471718T3 (da) Paracetamolholdigt farmaceutisk præparat
SE9502219D0 (sv) Novel medical use
ATE107165T1 (de) Verwendung von macrolactonen als antiallergica.
IT1242475B (it) Agente colinergico, in particolare glicil-p-ammino-piridina-anilide- monoacetato, per il trattamento degli stati di demenza senile.
FR2654343B1 (fr) Utilisation d'un polypeptide ayant l'activite de l'interferon gamma pour la preparation de compositions pharmaceutiques destinees au traitement de cancers primitifs de la plevre.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 466833

Country of ref document: ES